Mizuho Medy Co., Ltd. (4595)
JPX JPX Primary Summary
Mizuho Medy Co., Ltd. (4595) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Mizuho Medy Co., Ltd. ever had a stock split?
Mizuho Medy Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | JPX Exchange | JP3885900005 ISIN |
| Japan Country | 193 Employees | 29 Jun 2026 Last Dividend | 29 May 2018 Last Split | - IPO Date |
Overview
Mizuho Medy Co., Ltd., founded in 1977 and based in Tosu, Japan, is a company dedicated to researching, developing, manufacturing, and selling in-vitro diagnostic products. It also provides related scientific and technical information services, mainly catering to the Japanese market. Mizuho Medy has a significant presence in international markets as well, including the United States, Belgium, Finland, Netherlands, Taiwan, Thailand, and others. The company's operations extend beyond manufacturing, involving import and export activities that underline its role in the global healthcare landscape.
Products and Services
The company offers a diverse range of in-vitro diagnostic products, including:
- Immunoassay Test Products: These are used for the detection of various viral and bacterial infections. They include influenza virus kits, RS virus and human metapneumovirus antigen test kits, streptococcus pneumoniae antigen and legionella antigen test kits, mycoplasma pneumoniae antigen test kits, adenovirus antigen test kits, rotavirus and adenovirus antigen test kits, norovirus antigen test kits, and group A streptococcal antigen test kits. Each kit is designed to provide quick and reliable diagnostics for specific pathogens.
- Pregnancy and Ovulation Test Kits: These kits are designed for home use, allowing individuals to determine pregnancy status or track ovulation cycles with ease and accuracy.
- Fecal Occult Blood Test Kits: These kits are used for screening and early detection of colorectal cancer by detecting hidden blood in stool, a sign of polyps or cancer.
- Gene Analysis Instrument: A sophisticated device designed for the detailed analysis of genes, providing valuable information for research and diagnosis of genetic disorders.
- SARS-CoV-2 Detection Kits: Used for the detection of the COVID-19 virus, these kits have become essential tools in the global effort to manage the pandemic.
- Mycoplasma Pneumoniae Nucleic Acid Kits: These kits are specialized in detecting the DNA or RNA of the Mycoplasma pneumoniae bacterium, enabling accurate diagnosis of infections caused by this organism.
In addition to its primary manufacturing and development operations, Mizuho Medy engages in import and export activities, underscored by its international presence. This broad range of products and services positions the company as a key player in the in-vitro diagnostics market, contributing significantly to public health globally.
